{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:11:31Z","timestamp":1789056691067,"version":"build-2803163510"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["P50 DK1147786"],"award-info":[{"award-number":["P50 DK1147786"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["CRN-2020-007"],"award-info":[{"award-number":["CRN-2020-007"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"crossref","award":["1306-01556"],"award-info":[{"award-number":["1306-01556"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>C3 glomerulopathy and immune complex\u2013associated membranoproliferative glomerulonephritis in children have similar degrees of proteinuria, hypoalbuminemia, hypertension, and hypocomplementemia at diagnosis.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>C3 glomerulopathy and immune complex\u2013associated membranoproliferative glomerulonephritis in children progress similarly to a composite outcome of CKD, dialysis, or kidney transplantation.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>A low level of C3 at baseline is associated with achieving the composite outcome.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>C3 glomerulopathy (C3G) and immune complex\u2013associated membranoproliferative glomerulonephritis (IC-MPGN) are rare complement-mediated kidney diseases with a high risk of progression to kidney failure. Little is known about the natural history of these diseases in children, limiting our understanding of risk factors for progressive kidney disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a computable phenotype algorithm, a pediatric cohort with C3G or IC-MPGN was identified at seven institutions in PEDSnet, a national network of pediatric health systems which aggregate electronic health record data and collaborate on pragmatic research studies. Discrete data elements were captured from electronic health records, and additional clinical and histopathologic data were extracted by standardized chart review by pediatric nephrologists. Biopsy diagnosis was classified as C3G or IC-MPGN by applying an algorithm on the basis of immunofluorescence and electron microscopy and supplemented with manual chart review. Kaplan\u2013Meier survival curves were used to compare the risk of reaching a composite kidney outcome of 50% reduction in eGFR, initiation of maintenance dialysis, or kidney transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 204 patients with membranoproliferative glomerulonephritis identified by the computable phenotype algorithm and chart review, 159 could be further classified as C3G or IC-MPGN on the basis of available biopsy data. There were no significant differences in baseline serum albumin, C3 level, urine protein\/creatinine ratio, or eGFR between C3G and IC-MPGN. Patients with C3G and IC-MPGN had similar rates of progression to the composite kidney outcome, and a low serum C3 level at baseline was associated with this composite outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Using large-scale, real-world multi-institutional data, we investigated the natural history of a large contemporary cohort of children with membranoproliferative glomerulonephritis. Because patients classified as having C3G compared with IC-MPGN had similar baseline clinical characteristics and rates of progressive disease despite untargeted treatment approaches, the availability of newer complement-targeted agents hold the promise of benefit to this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000001118","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:00:37Z","timestamp":1782144037000},"page":"1606-1620","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Natural History of C3 Glomerulopathy and Immune Complex-Associated Membranoproliferative Glomerulonephritis in Children"],"prefix":"10.2215","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3704-0922","authenticated-orcid":false,"given":"Bradley P.","family":"Dixon","sequence":"first","affiliation":[{"name":"Renal Section, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado"},{"name":"Children's Hospital Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Laskin","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine at the University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-4654","authenticated-orcid":false,"given":"Amy J.","family":"Goodwin Davies","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-1590","authenticated-orcid":false,"given":"Hanieh","family":"Razzaghi","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell G.","family":"Maltenfort","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0939-7993","authenticated-orcid":false,"given":"Sherin","family":"Meloni","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7232-7975","authenticated-orcid":false,"given":"Joseph T.","family":"Flynn","sequence":"additional","affiliation":[{"name":"Seattle Children's Hospital, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna J.","family":"Claes","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mitsnefes","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-7424","authenticated-orcid":false,"given":"Brian R.","family":"Stotter","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine, Saint Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8000-1385","authenticated-orcid":false,"given":"Vikas R.","family":"Dharnidharka","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine, Saint Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-2506","authenticated-orcid":false,"given":"Caroline A.","family":"Gluck","sequence":"additional","affiliation":[{"name":"Nemours Children's Health, Wilmington, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6786-6579","authenticated-orcid":false,"given":"Joshua","family":"Zaritsky","sequence":"additional","affiliation":[{"name":"Nemours Children's Health, Wilmington, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1815-322X","authenticated-orcid":false,"given":"Michael J.","family":"Somers","sequence":"additional","affiliation":[{"name":"Boston Children's Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Kallash","sequence":"additional","affiliation":[{"name":"The Research Institute at Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1982-9938","authenticated-orcid":false,"given":"William E.","family":"Smoyer","sequence":"additional","affiliation":[{"name":"The Research Institute at Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2081-5242","authenticated-orcid":false,"given":"Susan L.","family":"Furth","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine at the University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1252-068X","authenticated-orcid":false,"given":"Christopher B.","family":"Forrest","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine at the University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Denburg","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Perelman School of Medicine at the University of Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"2","key":"B1-20260910","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ndt\/gfab281","article-title":"Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment","volume":"38","author":"Noris","year":"2023","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"B2-20260910","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int."},{"key":"B3-20260910","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molimm.2016.01.010","article-title":"Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome","volume":"71","author":"Iatropoulos","year":"2016","journal-title":"Mol Immunol."},{"issue":"6","key":"B4-20260910","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int."},{"issue":"5","key":"B5-20260910","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ki.2015.227","article-title":"Effectiveness of mycophenolate mofetil in C3 glomerulonephritis","volume":"88","author":"Rabasco","year":"2015","journal-title":"Kidney Int."},{"issue":"2","key":"B6-20260910","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000479012","article-title":"Immunosuppressive treatment in C3 glomerulopathy: is it really effective?","volume":"46","author":"Caliskan","year":"2017","journal-title":"Am J Nephrol."},{"issue":"3","key":"B7-20260910","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2215\/CJN.09080817","article-title":"Mycophenolate mofetil in combination with steroids for treatment of C3 glomerulopathy: a case series","volume":"13","author":"Avasare","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"B8-20260910","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ckj\/sfy127","article-title":"Usefulness of mycophenolate mofetil in Indian patients with C3 glomerulopathy","volume":"12","author":"Bharati","year":"2019","journal-title":"Clin Kidney J."},{"issue":"5","key":"B9-20260910","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2215\/CJN.12901211","article-title":"Eculizumab for dense deposit disease and C3 glomerulonephritis","volume":"7","author":"Bomback","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"issue":"10","key":"B10-20260910","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2215\/CJN.01360215","article-title":"Eculizumab in pediatric dense deposit disease","volume":"10","author":"Oosterveld","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"B11-20260910","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00467-017-3619-2","article-title":"C3 glomerulopathy and eculizumab: a report on four paediatric cases","volume":"32","author":"Lebreton","year":"2017","journal-title":"Pediatr Nephrol."},{"issue":"1","key":"B12-20260910","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2017.11.019","article-title":"Patterns of clinical response to eculizumab in patients with C3 glomerulopathy","volume":"72","author":"Le Quintrec","year":"2018","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"B13-20260910","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/j.ajkd.2018.12.046","article-title":"C5 convertase blockade in membranoproliferative glomerulonephritis: a single-arm clinical trial","volume":"74","author":"Ruggenenti","year":"2019","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B14-20260910","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12882-023-03058-9","article-title":"Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study","volume":"24","author":"Welte","year":"2023","journal-title":"BMC Nephrol."},{"issue":"1","key":"B15-20260910","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.04700513","article-title":"C3 glomerulopathy: clinicopathologic features and predictors of outcome","volume":"9","author":"Medjeral-Thomas","year":"2014","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"B16-20260910","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.kint.2017.10.022","article-title":"C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy","volume":"93","author":"Bomback","year":"2018","journal-title":"Kidney Int."},{"issue":"3","key":"B17-20260910","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00467-021-05221-6","article-title":"Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort","volume":"37","author":"Michels","year":"2022","journal-title":"Pediatr Nephrol."},{"issue":"12","key":"B18-20260910","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.ekir.2020.09.019","article-title":"Long-term outcomes of C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis in children","volume":"5","author":"Kirpalani","year":"2020","journal-title":"Kidney Int Rep."},{"issue":"11","key":"B19-20260910","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2215\/CJN.00320121","article-title":"C3 glomerulopathy and related disorders in children: etiology-phenotype correlation and outcomes","volume":"16","author":"Wong","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"B20-20260910","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00467-024-06587-z","article-title":"C3 glomerulopathy in children: a European longitudinal study evaluating outcome","volume":"40","author":"Cappoli","year":"2025","journal-title":"Pediatr Nephrol."},{"issue":"12","key":"B21-20260910","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1681\/ASN.2019040365","article-title":"Using electronic health record data to rapidly identify children with glomerular disease for clinical research","volume":"30","author":"Denburg","year":"2019","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B22-20260910","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1377\/hlthaff.2014.0127","article-title":"PEDSnet: how a prototype pediatric learning health system is being expanded into a national network","volume":"33","author":"Forrest","year":"2014","journal-title":"Health Aff (Millwood)."},{"issue":"4","key":"B23-20260910","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/amiajnl-2014-002743","article-title":"PEDSnet: a national pediatric learning health system","volume":"21","author":"Forrest","year":"2014","journal-title":"J Am Med Inform Assoc."},{"issue":"9","key":"B24-20260910","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-153-9-201011020-00010","article-title":"Advancing the science for active surveillance: rationale and design for the observational medical outcomes partnership","volume":"153","author":"Stang","year":"2010","journal-title":"Ann Intern Med."},{"issue":"1","key":"B25-20260910","doi-asserted-by":"crossref","first-page":"e10264","DOI":"10.1002\/lrh2.10264","article-title":"Developing a systematic approach to assessing data quality in secondary use of clinical data based on intended use","volume":"6","author":"Razzaghi","year":"2022","journal-title":"Learn Health Syst."},{"issue":"3","key":"B26-20260910","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"B27-20260910","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.ekir.2023.08.033","article-title":"Clinical safety and efficacy of pegcetacoplan in a phase 2 study of patients with C3 glomerulopathy and other complement-mediated glomerular diseases","volume":"8","author":"Dixon","year":"2023","journal-title":"Kidney Int Rep."},{"issue":"1","key":"B28-20260910","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ekir.2024.09.030","article-title":"Efficacy and safety of pegcetacoplan in kidney transplant recipients with recurrent complement 3 glomerulopathy or primary immune complex membranoproliferative glomerulonephritis","volume":"10","author":"Bomback","year":"2025","journal-title":"Kidney Int Rep."},{"issue":"9","key":"B30-20260910","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s00467-024-06377-7","article-title":"Clinical characteristics and outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulopathy in Japanese children","volume":"39","author":"Ueda","year":"2024","journal-title":"Pediatr Nephrol."},{"issue":"4","key":"B31-20260910","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2215\/CJN.0000000953","article-title":"Natural history and clinical associations with long-term outcomes in primary C3 glomerulopathy and immune complex-mediated membranoproliferative glomerulonephritis","volume":"21","author":"Nanchen","year":"2026","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"B32-20260910","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrneph.2010.85","article-title":"C3 glomerulopathy: a new classification","volume":"6","author":"Fakhouri","year":"2010","journal-title":"Nat Rev Nephrol."},{"issue":"12","key":"B33-20260910","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1016\/j.ekir.2023.09.017","article-title":"Efficacy and safety of iptacopan in patients with C3 glomerulopathy","volume":"8","author":"Wong","year":"2023","journal-title":"Kidney Int Rep."},{"issue":"10512","key":"B34-20260910","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(25)01148-1","article-title":"Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study","volume":"406","author":"Kavanagh","year":"2025","journal-title":"Lancet."},{"issue":"22","key":"B35-20260910","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1056\/NEJMoa2501510","article-title":"Trial of pegcetacoplan in C3 glomerulopathy and immune-complex MPGN","volume":"393","author":"Fakhouri","year":"2025","journal-title":"N Engl J Med."},{"issue":"6","key":"B36-20260910","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00467-025-06673-w","article-title":"Efficacy of complement inhibition with pegcetacoplan in children with C3 glomerulopathy","volume":"40","author":"Mancuso","year":"2025","journal-title":"Pediatr Nephrol."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:00:52Z","timestamp":1789056052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000001118","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"2025-04-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}